Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · USD

$431

-9.38 (-2.1%)· Recorded snapshot

Market cap	10B
Revenue (ttm)	1.3B
Net income (ttm)	-325.1M
EPS (ttm)	-$14.2
Shares out	23.1M
Volume	268,715
Beta	-1.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3B
Net income (ttm): -325.1M
EPS (ttm): -$14.2
Market cap: 10B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-53.3

P25 n/aP50 n/aP75 n/a

ROIC-23.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MDGL indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001157601
Company name	Madrigal Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	558868105
Earnings date	2026-11-03
Earnings time	bmo
Employees	915
Employees change	387
Employees growth	73.3%
Enterprise value	$9.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US5588681057
Last 10-K release date	2026-02-19
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$10B
Market cap category	Large-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$430.96
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MDGL
U.S. state	Pennsylvania
Website	https://www.madrigalpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.3%
EV/Sales	7.4x
FCF / EV yield	-2.17%
FCF yield	-2.06%
Forward EV/Sales	5.32x
Forward P/S	5.6x
P/B ratio	19.42x
P/S ratio	7.78x
Price / tangible book value	19.35x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-25.13%
EBITDA margin	-25.01%
Gross margin	91.48%
Operating margin	-25.13%
Pretax margin	-25.32%
Profit margin	-25.32%
Profit per employee	$-355,295
Revenue per employee	$1.4M
ROA	-17.84%
ROA (5Y)	-42.5%
ROCE	-37.06%
ROE	-53.31%
ROE (5Y)	-101.57%
ROIC	-23.84%
SBC / revenue	9.46%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	136.62%
Gross profit growth (Q)	59.15%
Net income growth years	1
Revenue growth	149.04%
Revenue growth (Q)	71.17%
Revenue growth (QoQ)	17%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-8.6M
Depreciation and amortization	$1.5M
EBIT	$-322.6M
EBITDA	$-321.1M
EPS	$-14.22
FCF per share	$-8.93
Financing cash flow	$251M
Free cash flow	$-206.3M
Free cash flow minus SBC	$-327.7M
Gross profit	$1.2B
Investing cash flow	$47M
Net borrowing	$228.3M
Net cash flow	$101.7M
Net income	$-325.1M
Operating cash flow minus SBC	$-319.1M
Operating income	$-322.6M
Revenue	$1.3B
Stock-based compensation	$121.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.29
Book value per share	$22.68
Debt / equity	0.66
Interest coverage	-10.24
Long-term assets	$45.5M
Long-term liabilities	$346.7M
Net cash (debt)	$491M
Net cash / market cap	4.91%
Net cash growth	-27.05%
Net debt / equity	-0.94
Piotroski F-Score	2
Property, plant and equipment	$17.2M
Shareholders' equity	$523.7M
Tangible book value	$516.5M
Tangible book value per share	$22.37
Total assets	$1.2B
Total cash	$838.8M
Total debt	$347.8M
Total liabilities	$720.9M
WACC	-1.24%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.14
Current assets	$1.2B
Current liabilities	$374.2M
Current ratio	3.2
Inventory turnover	1.34
Net working capital	$-12.7M
Quick ratio	2.76
Working capital	$825M
Working capital turnover	1.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.96%
Dividend yield	0%
Shareholder yield	-3.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	2,419.01%
10Y return CAGR	38.08%
10Y total return	2,419.01%
150-day SMA	$512.81
1D price change	-2.13%
1M price change	-17.15%
1M total return	-17.15%
1W price change	-8.46%
1W total return	-8.46%
1Y price change	-1.79%
1Y return CAGR	-1.79%
1Y total return	-1.79%
20-day SMA	$464.03
200-day SMA	$500.62
3M price change	-22.36%
3M total return	-22.36%
3Y price change	255.47%
3Y return CAGR	52.6%
3Y total return	255.47%
50-day SMA	$502.54
50-day SMA vs 200-day SMA	50over200
52-week high	$615.00
52-week high date	2025-12-24
52-week low	$393.61
52-week low date	2025-10-29
5Y price change	476.56%
5Y return CAGR	41.97%
5Y total return	476.56%
6M price change	-17.71%
6M total return	-17.71%
All-time high	$615.00
All-time high date	2025-12-24
All-time low	$6.60
All-time low date	2016-08-02
Average true range (ATR)	$16.49
Average volume	295.2K
Beta (1Y)	-0.15
Beta (2Y)	0.27
Beta (5Y)	-1.05
Change from 52-week high	-29.93%
Change from 52-week low	9.49%
Change from all-time high	-30.41%
Change from all-time low	6,384.55%
Change from open	-1.15%
Day's gap	-0.99%
Dollar volume	$115.8M
High price	$437.17
Low price	$426.72
Monthly RSI	50.75
Open price	$435.96
Position in 52-week range	40.57%
Premarket change	-0.07%
Premarket close	$440.33
Premarket price	$440.00
Premarket volume	244
Previous close	$440.33
Price vs 150-day SMA	-16.54%
Price vs 20-day SMA	-7.77%
Price vs 200-day SMA	-14.51%
Price vs 50-day SMA	-14.84%
Relative volume	0.91
RSI	28.62
Sharpe ratio	0.08
Sharpe ratio (3Y)	0.94
Sharpe ratio (5Y)	0.56
Sortino ratio	0.26
Sortino ratio (3Y)	1.64
Sortino ratio (5Y)	2.06
Volume	268.7K
Weekly RSI	35.24
YTD price change	-26.51%
YTD total return	-26.51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.7M
Float percentage	59.4%
Shares change (QoQ)	-20.53%
Shares change (YoY)	3.96%
Shares held by insiders	5.25%
Shares held by institutions	71.82%
Shares outstanding	23.1M
Short % of float	15.99%
Short % of shares	9.5%
Short ratio	10.8 days

Deeper analysis on MDGL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MDGL report

Is a complete MDGL research report available?

No complete published report is available for Madrigal Pharmaceuticals, Inc. (MDGL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Madrigal Pharmaceuticals, Inc. (MDGL)

Price

Financial snapshot

Fair-value bridge

Latest news · MDGL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MDGL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MDGL

Frequently asked questions